CRIS Current Research Information System

PASCALE, RENATO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.970
NA - Nord America 3.634
EU - Europa 2.850
SA - Sud America 327
AF - Africa 231
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.041
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.513
SG - Singapore 1.356
CN - Cina 1.311
IT - Italia 1.212
VN - Vietnam 1.121
HK - Hong Kong 314
DE - Germania 307
SE - Svezia 282
KR - Corea 236
BR - Brasile 216
GB - Regno Unito 203
IN - India 173
FR - Francia 164
NL - Olanda 132
BD - Bangladesh 112
IE - Irlanda 111
JP - Giappone 97
RU - Federazione Russa 94
CI - Costa d'Avorio 84
FI - Finlandia 82
CA - Canada 71
BG - Bulgaria 44
AR - Argentina 41
AT - Austria 41
JO - Giordania 36
TG - Togo 36
ID - Indonesia 33
IQ - Iraq 33
ZA - Sudafrica 31
CH - Svizzera 28
TH - Thailandia 26
ES - Italia 24
MX - Messico 24
TR - Turchia 23
AU - Australia 22
PH - Filippine 22
BE - Belgio 21
NG - Nigeria 21
PK - Pakistan 20
UA - Ucraina 19
PL - Polonia 18
CL - Cile 16
CO - Colombia 16
EC - Ecuador 14
SC - Seychelles 14
RO - Romania 12
SA - Arabia Saudita 12
EG - Egitto 8
PE - Perù 8
TW - Taiwan 8
DZ - Algeria 7
LT - Lituania 7
GR - Grecia 6
HN - Honduras 6
PY - Paraguay 6
TN - Tunisia 6
AL - Albania 5
EE - Estonia 5
IR - Iran 5
MA - Marocco 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
HR - Croazia 4
JM - Giamaica 4
MY - Malesia 4
PA - Panama 4
UZ - Uzbekistan 4
VE - Venezuela 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
KE - Kenya 3
LY - Libia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AO - Angola 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
LU - Lussemburgo 2
MK - Macedonia 2
NE - Niger 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
VI - Stati Uniti Isole Vergini 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BZ - Belize 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
Totale 12.017
Salva come PNG Salva come JPEG
Città #
Singapore 951
Ashburn 503
Hefei 495
Chandler 317
Ho Chi Minh City 302
Hong Kong 291
Hanoi 270
San Jose 269
Bologna 225
Seoul 211
Santa Clara 170
Milan 125
Southend 125
Boardman 124
Dallas 124
Beijing 116
Dublin 111
Fairfield 107
New York 107
Los Angeles 86
Abidjan 84
Princeton 80
Tokyo 80
Council Bluffs 73
Lauterbourg 73
Ann Arbor 68
Rome 58
Da Nang 52
Wilmington 52
Bengaluru 51
Helsinki 51
Woodbridge 47
Florence 46
Houston 45
Bremen 44
Seattle 44
Sofia 43
São Paulo 41
Munich 40
Haiphong 38
Lomé 36
Amman 35
Buffalo 33
Redondo Beach 33
Vienna 32
Turin 31
Frankfurt am Main 29
Berlin 28
Shanghai 28
Jakarta 23
Cambridge 22
Chicago 22
The Dalles 22
Bern 21
Lappeenranta 21
Nuremberg 20
Orem 20
Amsterdam 19
Johannesburg 19
London 19
Modena 19
Toronto 19
Brussels 18
Victoria 18
Abeokuta 17
Redmond 17
Des Moines 16
Falkenstein 15
Montreal 15
Paris 15
Redwood City 15
Washington 15
Atlanta 14
Guangzhou 14
Quận Bình Thạnh 14
Rimini 14
Tongling 14
Baghdad 13
Biên Hòa 13
Can Tho 13
Denver 13
Jinan 13
Naples 13
Phoenix 13
Castel Maggiore 12
Hải Dương 12
Westminster 12
Adelaide 11
Changsha 11
Ha Long 11
Mexico City 11
Stockholm 11
Thái Nguyên 11
Xi'an 11
Bangkok 10
Bogotá 10
Boydton 10
Bến Tre 10
Ferrara 10
Genoa 10
Totale 7.185
Salva come PNG Salva come JPEG
Nome #
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 328
Artificial Intelligence model to predict resistances in Gram-negative bloodstream infections 294
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study 274
The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection 258
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 254
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 254
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 249
A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia 248
Carbapenem resistant bacteria in Intensive Care Unit during COVID-19 pandemic: Multicenter before-after cross sectional study 234
Impact on mortality of a bundle for the management of enterococcal bloodstream infection 229
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study 224
Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study 211
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 205
Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. 204
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections 201
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 199
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 198
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 195
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 183
Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin–Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Enterobacterales Secondary Bloodstream Infections: Findings from a Prospective Pilot Study 178
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 177
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study 174
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 170
A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study 166
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 166
COVID-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study 165
Prognostic utility of the new definition of difficult-to-treat resistance among patients with gram-negative bloodstream infections 165
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients 162
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study 159
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 158
Multidisciplinary Management of Sternal Osteomyelitis Due to Klebsiella aerogenes after Open Heart Surgery in a Patient with Multiple Myeloma: A Case Report and Discussion of the Literature 157
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 156
CMV-RNAemia as new marker of active viral replication in transplant recipients 156
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 155
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 155
Cefiderocol for the Treatment of Nosocomial Bloodstream Infections Caused by Stenotrophomonas maltophilia: A Case Series and Literature Review 153
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 152
Antibiotic Prophylaxis in Patients Undergoing Lung Transplant: Single-Center Cohort Study 149
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 148
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized with COVID-19 Pneumonia: A Randomized Clinical Trial 148
Population Pharmacokinetic and Pharmacodynamic Analysis for Maximizing the Effectiveness of Ceftobiprole in the Treatment of Severe Methicillin-Resistant Staphylococcal Infections 145
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 142
Current role of ceftobiprole in the treatment of hospital-acquired and community-acquired pneumonia: expert opinion based on literature and real-life experiences 141
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 140
The Role of Microbes in Surgical Decision Making for Infective Endocarditis: Mitral Valve Repair or Replacement? 139
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 138
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis 137
‘Treatment duration for Escherichia coli bloodstream infection and outcomes’ – Author's reply 135
Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients 134
Current Practice Patterns and Educational Needs of the ESCMID Study Group for Infections in Compromised Hots 133
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 131
Infections Management in the Lung Transplant Setting in Italy: A Web-Survey 130
Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicenter observational study (CarDINe Study) 130
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 126
Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda 119
Pseudozyma aphidis bloodstream infection in a patient with aggressive lymphoma and a history of intravenous drug use: Case report and review of the literature 119
Impact on clinical outcome of follow-up blood cultures and risk factors for persistent bacteraemia in patients with gram-negative bloodstream infections: a systematic review with meta-analysis 115
Early Onset of Tenofovir-Related Fanconi Syndrome in a Child with Acute Hepatitis B: A Case Report and Systematic Review of Literature 115
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in solid organ transplant recipients 112
Antimicrobial and resource utilization with T2 magnetic resonance for rapid diagnosis of bloodstream infections: systematic review with meta-analysis of controlled studies 109
Management of heart transplant candidates in the time of COVID-19 pandemic: Looking for answers 107
Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study 105
Prognostic role of aetiological agent vs. clinical pattern in candidates to lead extraction for cardiac implantable electronic device infections 103
ORCHESTRA Delphi consensus: clinical management of SARS-CoV-2 infection in people with HIV 102
Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study 94
null 91
Epidemiology and antibiotic resistance in a large italian teaching hospital 89
Central venous catheter-related biofilm infections: An up-to-date focus on meticillin-resistant Staphylococcus aureus 84
Exposure to psychotropic medications and COVID-19 course after hospital admission: Results from a prospective cohort study 80
What is the impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections? 79
null 78
Treatment duration for Escherichia coli bloodstream infection and outcomes: Retrospective single-centre study 76
Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections 74
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful? 69
Validation and prognostic utility of a definition of uncomplicated Gram-negative bloodstream infection 66
Implementation of a Bundle for the Management of Patients With Gram-Negative Bloodstream Infection: A Pre-Post Quasi-experimental Study 62
Pseudomonas aeruginosa bloodstream infections in internal medicine wards: A large Italian multicenter retrospective study 59
Treatment of Stenotrophomonas malthophilia bloodstream infections from guidance to real life: multicenter retrospective cohort study 59
Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort study 58
Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infections 56
Intestinal helminths in immigrants in Naples (Italy): A comparison between two different diagnostic techniques 51
Sphingomonas paucimobilis osteomyelitis in an immunocompetent patient. A rare case report and literature review 50
From clinical trials to daily practice: How to adequately administer sulbactam-durlobactam? alone or combined with imipenem? 43
SARS-CoV-2 VACCINATION AND EARLY SPECIFIC IMMUNE RESPONSE IN SOLID ORGAN TRANSPLANT RECIPIENTS 42
How to manage patients receiving long-term suppressive antibiotic treatment for infective endocarditis: The role of [18F]-FDGCT/CT imaging-An international multidisciplinary survey 37
Pharmacokinetic/Pharmacodynamic Analysis of High-Dose Daptomycin in Combination with Continuous Infusion Ceftobiprole in a Case Series of Documented Staphylococcal Bacteremia or Endocarditis: Is There Any Room for TDM-Guided Dosing Reduction? 36
Progression From Carriage to Bloodstream Infection and Fatality by Different Enterobacterales Species, Carbapenemases, and Host Settings: Deciphering the Melting Pot 33
Antipseudomonal cephalosporins versus piperacillin/tazobactam or carbapenems for the definitive antibiotic treatment of Pseudomonas aeruginosa bacteraemia: new kids on the ICU block? 31
Resistant/Refractory Cytomegalovirus Retinitis in Solid Organ and Hematopoietic Stem Cell Transplant Recipients: The Cause-or-Consequence Dilemma 30
Totale 12.345
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.292
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202187 0 0 0 0 0 0 0 0 0 0 0 87
2021/2022810 18 10 25 77 63 41 26 54 78 113 181 124
2022/20231.346 89 161 61 191 106 122 35 104 255 48 103 71
2023/2024656 72 69 33 60 46 100 31 36 35 61 50 63
2024/20252.342 87 199 210 218 274 129 168 92 64 201 232 468
2025/20266.499 625 811 581 582 545 274 704 171 1.091 452 370 293
Totale 12.345